Market Tracker

10/20 3:58pm ET

Compugen Ltd (NASDAQ:CGEN)

3.80
Delayed Data
As of 3:40pm ET
 -0.10 / -2.56%
Today’s Change
2.60
Today|||52-Week Range
6.80
-25.49%
Year-to-Date
Company News For Oct 10, 2017
Oct 10 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close3.90
Today’s open3.95
Day’s range3.70 - 3.95
Volume28,587
Average volume (3 months)117,205
Market cap$199.4M
Dividend yield--
Data as of 3:40pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-55.00%
Earnings growth (this year)-17.74%
Earnings growth (next 5 years)--
Revenue growth (last year)-92.33%
P/E ratioNM
Price/Sales364.28
Price/Book3.14

Competitors

 Today’s
change
Today’s
% change
FATEFate Therapeutics In...+0.08+1.95%
VSTMVerastem Inc0.000.00%
VBIVVBI Vaccines Inc-0.05-1.40%
VBLTVascular Biogenics L...0.000.00%
Data as of 3:58pm ET, 10/20/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$712.0K
Annual profit (last year)-$31.5M
Net profit margin-4,425.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Co-
Chief Executive Officer
Martin S. Gerstel
President &
Co-Chief Executive Officer
Anat Cohen-Dayag
Corporate headquarters
Holon, Tel Aviv

Forecasts